• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND PULSAR-18 5/120/90; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND PULSAR-18 5/120/90; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 366814
Device Problem Material Deformation (2976)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/17/2019
Event Type  malfunction  
Event Description
A pulsar-18 was chosen to treat a calcified lesion in a tortuous left sfa.After deployment the stent looked crushed.Despite post-dilatation the angiographic images showed a deranged stent.A second stent was placed inside the defected area with good result.
 
Manufacturer Narrative
The complaint instrument was not returned to biotronik.Therefore no technical investigation on the subject could be performed.The corresponding production documentation as well as low resolution pictures taken from the angiographic images were reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.In the pictures taken from the angiographic images geometric distortions of the stent structure are visible.The inhomogeneous radiopacity along the stent length may be suggestive of stent compression.The review of the production documentation of the product detailed above verified that the instrument was manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the conducted investigations, no manufacturing related root cause could be determined.It therefore seems likely that the root cause for the complaint event is related to external factors during the procedure.However, it should be noted that, according to the ifu, placement of the pulsar-18 stent in the popliteal artery is contraindicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSAR-18 5/120/90
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key8689246
MDR Text Key147727477
Report Number1028232-2019-02327
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P160025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/30/2021
Device Model Number366814
Device Catalogue NumberSEE MODEL NO.
Device Lot Number05185524
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/28/2019
Initial Date FDA Received06/11/2019
Supplement Dates Manufacturer Received07/23/2019
Supplement Dates FDA Received07/29/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-